Replies to post #85036 on Creative Medical Technology Holdings Inc (CELZ)

[escalate]

I'm guessing those institutional investors are putting up something like 100k at a time to get that information. And even with that, they may not be getting all the details either. Send an email to the company and ask ?

[monte379]

I hope like you we get to see that as well. Not to argue over a few hundred bucks, but I think the revs per kit is closer to $1000-1200/ kit. That was from some DD by a buddy, and a hard look at the Q. I tried to find the price of the kit from the part number but could not find it. Even if I did, we have no idea what the deal with CELZ is if they buy in bulk etc. etc.

Regardless, that is the revenue source at this stage IMO. And that is not too shabby once they get say 20+ docs doing let’s say 5 per week and keep increasing. I assume StemSpine will be similar. No clue how AmnioStem will work.

It all seems pretty simple to me. Build a better mousetrap and sell the cheese so it can be used. Sounds like a nice low overhead plan for CELZ.

[monte379]

From the Q filing... Plan of Operations - We commenced marketing disposable stem cell separation kits for the Caverstem® ED treatment in the fourth quarter of 2017. We commenced marketing disposable stem cell separation kits for the FemCelz™ procedure to treat female sexual disfunction in the fourth quarter of 2018. For the next 12 months our plan of operations is to market our disposable kits, publish the results of the UCLA/LABiomed clinical trial and partner with leading researchers on investigator-initiated trials to advance our neurological programs.....